Intravascularly Administered RGD-Displaying Measles Viruses Bind to and Infect Neovessel Endothelial Cells In Vivo
Open Access
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (6) , 1012-1021
- https://doi.org/10.1038/mt.2009.39
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Affinity Thresholds for Membrane Fusion Triggering by Viral GlycoproteinsJournal of Virology, 2007
- Viruses as anticancer drugsTrends in Pharmacological Sciences, 2007
- Targeting lung cancer using an infectivity enhanced CXCR4-CRAdLung Cancer, 2007
- Methods for Delivery of Adenoviral Vectors to Tumor VasculatureHuman Gene Therapy, 2007
- Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirusMolecular Cancer Therapeutics, 2006
- Efficient targeting of adenoviral vectors to integrin positive vascular cells utilizing a CAR-cyclic RGD linker proteinBiochemical and Biophysical Research Communications, 2005
- Oncolytic adenoviruses – selective retargeting to tumor cellsOncogene, 2005
- Rescue and propagation of fully retargeted oncolytic measles virusesNature Biotechnology, 2005
- Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell markerBlood, 2003
- An Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene ExpressionMolecular Therapy, 2001